{
  "bundleVersion": "0.1",
  "title": "Joint Statement of the Multilateral Leaders Task Force on COVID-19 Vaccines, Therapeutics, and Diagnostics for Developing Countries following its Second Meeting",
  "sourceUrl": "https://www.imf.org/en/news/articles/2021/07/30/pr21241-joint-statement-task-force-covid-19-vaccines-therapeutics-diag-dev-countries-2nd-meeting",
  "generatedAtUtc": "2026-09-26T00:35:44.387Z",
  "generator": {
    "name": "imf-overlay-generator",
    "version": "1.0.0"
  },
  "entries": [
    {
      "path": "/en/news/articles/2021/07/30/pr21241-joint-statement-task-force-covid-19-vaccines-therapeutics-diag-dev-countries-2nd-meeting/index.md",
      "role": "landing-page",
      "audience": "llm",
      "format": "markdown",
      "title": "Joint Statement of the Multilateral Leaders Task Force on COVID-19 Vaccines, Therapeutics, and Diagnostics for Developing Countries following its Second Meeting",
      "sourceUrl": "https://www.imf.org/en/news/articles/2021/07/30/pr21241-joint-statement-task-force-covid-19-vaccines-therapeutics-diag-dev-countries-2nd-meeting",
      "sizeBytes": 5275
    },
    {
      "path": "/en/news/articles/2021/07/30/pr21241-joint-statement-task-force-covid-19-vaccines-therapeutics-diag-dev-countries-2nd-meeting/index.html",
      "role": "landing-page",
      "audience": "crawler",
      "format": "html",
      "title": "Joint Statement of the Multilateral Leaders Task Force on COVID-19 Vaccines, Therapeutics, and Diagnostics for Developing Countries following its Second Meeting",
      "sourceUrl": "https://www.imf.org/en/news/articles/2021/07/30/pr21241-joint-statement-task-force-covid-19-vaccines-therapeutics-diag-dev-countries-2nd-meeting",
      "sizeBytes": 10415
    },
    {
      "path": "/en/news/articles/2021/07/30/pr21241-joint-statement-task-force-covid-19-vaccines-therapeutics-diag-dev-countries-2nd-meeting/index.json",
      "role": "landing-page",
      "audience": "agent",
      "format": "json",
      "title": "Joint Statement of the Multilateral Leaders Task Force on COVID-19 Vaccines, Therapeutics, and Diagnostics for Developing Countries following its Second Meeting",
      "sourceUrl": "https://www.imf.org/en/news/articles/2021/07/30/pr21241-joint-statement-task-force-covid-19-vaccines-therapeutics-diag-dev-countries-2nd-meeting",
      "sizeBytes": 7577
    },
    {
      "path": "/en/news/articles/2021/07/30/pr21241-joint-statement-task-force-covid-19-vaccines-therapeutics-diag-dev-countries-2nd-meeting/bundle-manifest.json",
      "role": "bundle-guide",
      "audience": "agent",
      "format": "json",
      "title": "Bundle Manifest",
      "sourceUrl": "https://www.imf.org/en/news/articles/2021/07/30/pr21241-joint-statement-task-force-covid-19-vaccines-therapeutics-diag-dev-countries-2nd-meeting",
      "sizeBytes": 2373
    }
  ]
}